Cardlytics, Inc. — Director's Dealing 2020

May 29, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cardlytics, Inc. (CDLX)
CIK: 0001666071
Period of Report: 2020-05-28

Reporting Person: SOMERS KIRK (Chief Legal & Privacy Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-28	Common Stock	M	13108	$20	Acquired	88525	Direct
2020-05-28	Common Stock	M	917	$20	Acquired	89442	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-05-28	Employee Stock Option (Right to Buy)	$20.0	M	13108	Disposed	2026-08-02	Common Stock (13108.0)	Direct
2020-05-28	Employee Stock Option (Right to Buy)	$20.0	M	917	Disposed	2026-12-06	Common Stock (917.0)	Direct

Footnotes

F1: This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on June 15, 2017 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period.

F2: This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on December 6, 2017 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period.